Keyphrases
Hydrogen Sulfide Donor
83%
Hydrogen Sulfide
63%
AP39
50%
Transdermal Delivery
50%
COVID-19
38%
Controlled Release
36%
Mitochondrial Targeting
33%
Sodium Thiosulfate
33%
Liposomes
31%
H2S Donors
30%
Elastic Liposomes
26%
Tween 20
26%
COVID-19 Infection
25%
SH-SY5Y Cells
25%
Molecular Mechanism
24%
Urea
23%
Mitochondrial Dysfunction
22%
Neurological Disorders
22%
Angiogenic
20%
Aqueous Gel
20%
Skin Cancer
20%
Loaded Liposomes
20%
Deformable
20%
Oxidative Stress
19%
H2O2-induced Oxidative Stress
19%
Mitochondria
18%
Gel Formulation
18%
Nanoparticles
17%
Neutrophil-lymphocyte Ratio
17%
Epigallocatechin
16%
Vascular Function
16%
Neuroprotective Effect
16%
Intracellular Uptake
16%
Apgar Score
16%
Ethnic Groups
16%
Vascular Disease
16%
Central Nervous System
16%
Induced Immunity
16%
Single-center Study
16%
Neonatal Apgar
16%
Immunological Response
16%
Blood Parameters
16%
Poly(lactic-co-glycolic acid)
16%
Prognostic Marker
16%
Polymeric Carriers
16%
Hydrogen Sulfide Signaling
16%
Neurological Conditions
16%
Therapeutic Intervention
16%
Angiogenic Potential
16%
Ex Vivo Studies
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hydrogen Sulfide
100%
Liposome
86%
Transdermal Delivery
50%
Propylene Glycol
33%
Infection
33%
Polysorbate 20
26%
Premature Labor
25%
Inflammation
20%
Controlled Release
20%
Skin Cancer
20%
Drug Delivery System
18%
Epigallocatechin
16%
Lactate Dehydrogenase
16%
Sodium Thiosulfate
16%
Hypoxia
16%
Oxidopamine
16%
Naringenin
16%
Vascular Disease
16%
Severe Acute Respiratory Syndrome
16%
Low Birth Weight
16%
Preeclampsia
16%
Blood-Brain Barrier
16%
Polyvinyl Alcohol
16%
Antioxidant
15%
Hydroxypropylmethylcellulose
13%
Neuroblastoma
12%
Parkinson's Disease
12%
Trehalose
12%
High Performance Liquid Chromatography
10%
Diseases
10%
Neuroprotective Agent
8%
Central Nervous System Disease
8%
Biomaterial
8%
Reactive Sulfur Species
8%
Elimination
8%
Therapeutic Use
8%
Perinatal Mortality
8%
Perinatal Morbidity
8%
Anti-Inflammatory Drug
8%
Maternal Mortality
8%
Hydrogen Peroxide
8%
Controlled Release Formulation
7%
Seahorse
5%
Transdermal
5%
Penetration Enhancing Agent
5%